United States · Wires & real time · Bloomberg
Moderna, Merck Fall After Melanoma Data Leak
Moderna and Merck shares plummeted after data on the companies' personalized melanoma vaccine wasn't enough to prove to investors that a new era of cancer treatments has arrived.…
Read the full article on Bloomberg Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

